In today’s newsletter: Holyrood plans to restrict fishing have been welcomed by conservationists and condemned by those for whom the seas provide an income – is there a compromise?
New York, June 5: A new pill has shown promise of reducing the risk of death from lung cancer by half, according to results of a decade-long global clinical trial.
Taking the drug osimertinib, developed by AstraZeneca, after surgery dramatically reduced the risk of patients dying by 51 per cent, showed results presented at the American Society of Clinical Oncology's (Asco) annual meeting in Chicago., Health News, Times Now
Thousands of bowel cancer patients each year could be spared the gruelling side-effects of radiotherapy with no impact on their survival chances, a trial has fo
A new pill has shown promise of reducing the risk of death from lung cancer by half, according to results of a decade-long global clinical trial.Taking the drug osimertinib, developed by AstraZeneca, after surgery dramatically reduced the risk .